DNB Related Funding Opportunities

Program Announcements

• Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) PAR-21-281
• Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) PAR-20-097
• NIDA Program Project Grant Applications (P01 Clinical Trial Optional) PAR-19-345

Request for Applications

• Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional) RFA-DA-22-009
• Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) RFA-OD-21-003
• Tobacco Regulatory Science (R01 Clinical Trial Optional) RFA-OD-21-002

Notices of Special Interest (NOSI)

• Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects NOT-OD-21-127 - 333,R03,R01,R21
• Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience NOT-DA-21-030 - R01,R21,R03,DP2,DP1,K99/R00,K01,R36,P01,R15,K24

Notices

• Notice of Correction to Key Dates for PAR-19-345 " NIDA Program Project Grant Applications (P01 Clinical Trial Optional)" NOT-DA-19-071

Notices

• Notice of Participation in PAR-18-721 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed) NOT-NS-18-053

Program Announcements

• NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) PAR-20-267
• Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) PAR-20-225
• Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) PAR-20-224
• NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) PAR-20-221
• Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) PAR-20-147
• Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) PAR-20-148
• NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) PAR-19-259

Request for Applications

• BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed) RFA-DA-21-006

Notices of Special Interest (NOSI)

• Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience NOT-DA-20-022 - R01,R21
• Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in Substance Use Disorder and/or HIV-related processes NOT-DA-20-018 - R01,R03,R21,333
• Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain NOT-DA-20-039 - R01,R03,R21
• Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders NOT-DA-20-030 - R01,P50,P01
• Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders NOT-DA-20-031 - R01,R03,R21,333,R21/R33
• Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics NOT-DA-20-009 - R01,R03,R21
• Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research NOT-DA-19-041 - R01,R21,R03

Notices

• Notice of Change to PAR-18-437"Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)" NOT-DA-19-042

Program Announcements

• Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional) PAR-19-310
• Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) PAR-19-282
• Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) PA-19-200
• Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) PA-19-201
• Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) PAR-19-162
• Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) PAR-19-163

Request for Applications

• The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) RFA-OD-19-029

Notices

• Notice of Additional Funds Available for PAS-18-624, " Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)" NOT-DA-18-048
• Notice of Additional Funds Available for PAS-18-625, " Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)" NOT-DA-18-049

Notices

• BRAIN Initiative: Notice of Support for Research on the Fundamental Neurobiology of Endogenous Opioid Systems NOT-DA-18-046
• Notice of Change to the Open Date in PA-18-917, " Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) NOT-DA-18-044
• Notice of Change to the Eligibility of Foreign Components in PA-18-060, " Neuroscience Research on Drug Abuse (R01)" NOT-DA-18-042
• Notice of Change to the Eligibility of Foreign Components in PA-18-078, " Neuroscience Research on Drug Abuse (R21)" NOT-DA-18-043